Drug trial for chronic shoulder pain halted early

NCT ID NCT05758415

Summary

This study tested whether a drug called secukinumab, given as an injection, could reduce pain and improve movement in adults with persistent, painful shoulder tendon problems. About 60 participants with moderate-to-severe pain that hadn't improved with standard treatments like physical therapy and painkillers were involved. The trial was stopped early by the company to focus on other projects, so final results are not available.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ROTATOR CUFF TENDINOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Conquest Research

    Winter Park, Florida, 32789, United States

  • Horizon Clinical Research

    La Mesa, California, 91942, United States

  • LV Research

    Las Vegas, Nevada, 89119, United States

  • Medvin Clinical Research

    Van Nuys, California, 91405, United States

  • Novartis Investigative Site

    Wuhan, CHN, 430033, China

  • Novartis Investigative Site

    Shijiazhuang, Hebei, 050051, China

  • Novartis Investigative Site

    Wuhan, Hubei, 430022, China

  • Novartis Investigative Site

    Xian, Shanxi, 710004, China

  • Novartis Investigative Site

    Chengdu, Sichuan, 610041, China

  • Novartis Investigative Site

    Shanghai, 200040, China

  • Novartis Investigative Site

    Milan, MI, 20157, Italy

  • Novartis Investigative Site

    Siena, SI, 53100, Italy

  • Novartis Investigative Site

    Krakow, 31-141, Poland

  • Novartis Investigative Site

    Swidnica, 85-100, Poland

  • Novartis Investigative Site

    Torun, 87-100, Poland

  • Novartis Investigative Site

    Warsaw, 00-874, Poland

  • Novartis Investigative Site

    Warsaw, 02-677, Poland

  • Novartis Investigative Site

    Santiago, A Coruna, 15705, Spain

  • Novartis Investigative Site

    Sabadell, Barcelona, 08208, Spain

  • Novartis Investigative Site

    A Coruña, 15006, Spain

  • Novartis Investigative Site

    Madrid, 28034, Spain

  • Novartis Investigative Site

    Valencia, 46024, Spain

  • Novartis Investigative Site

    Bangkok, 10400, Thailand

  • Novartis Investigative Site

    Chiang Mai, 50200, Thailand

Conditions

Explore the condition pages connected to this study.